• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SigsPack,用于癌症突变特征的软件包。

SigsPack, a package for cancer mutational signatures.

机构信息

Core Unit Bioinformatics, Berlin Institute of Health, Charitéplatz 1, Berlin, 10117, Germany.

Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Robert-Rössle-Str. 10, Berlin, 13092, Germany.

出版信息

BMC Bioinformatics. 2019 Sep 2;20(1):450. doi: 10.1186/s12859-019-3043-7.

DOI:10.1186/s12859-019-3043-7
PMID:31477009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6720940/
Abstract

BACKGROUND

Mutational signatures are specific patterns of somatic mutations introduced into the genome by oncogenic processes. Several mutational signatures have been identified and quantified from multiple cancer studies, and some of them have been linked to known oncogenic processes. Identification of the processes contributing to mutations observed in a sample is potentially informative to understand the cancer etiology.

RESULTS

We present here SigsPack, a Bioconductor package to estimate a sample's exposure to mutational processes described by a set of mutational signatures. The package also provides functions to estimate stability of these exposures, using bootstrapping. The performance of exposure and exposure stability estimations have been validated using synthetic and real data. Finally, the package provides tools to normalize the mutation frequencies with respect to the tri-nucleotide contents of the regions probed in the experiment. The importance of this effect is illustrated in an example.

CONCLUSION

SigsPack provides a complete set of tools for individual sample exposure estimation, and for mutation catalogue & mutational signatures normalization.

摘要

背景

突变特征是致癌过程将体细胞突变引入基因组的特定模式。已经从多个癌症研究中鉴定和量化了几种突变特征,其中一些与已知的致癌过程有关。确定导致样本中观察到的突变的过程对于了解癌症病因具有潜在的信息价值。

结果

我们在这里介绍 SigsPack,这是一个 Bioconductor 包,用于估计样本对一组突变特征所描述的突变过程的暴露程度。该包还提供了使用引导法估计这些暴露稳定性的功能。使用合成数据和真实数据验证了暴露和暴露稳定性估计的性能。最后,该包提供了工具,可根据实验中探测到的区域的三核苷酸含量对突变频率进行归一化。在一个示例中说明了这种效果的重要性。

结论

SigsPack 提供了一套完整的工具,用于单个样本暴露估计以及突变目录和突变特征的归一化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fad/6720940/e993d56b6064/12859_2019_3043_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fad/6720940/15a9619696d6/12859_2019_3043_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fad/6720940/dd960846b1f8/12859_2019_3043_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fad/6720940/b7990f8ea1ed/12859_2019_3043_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fad/6720940/1acc12681946/12859_2019_3043_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fad/6720940/b10d6aaf875e/12859_2019_3043_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fad/6720940/e993d56b6064/12859_2019_3043_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fad/6720940/15a9619696d6/12859_2019_3043_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fad/6720940/dd960846b1f8/12859_2019_3043_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fad/6720940/b7990f8ea1ed/12859_2019_3043_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fad/6720940/1acc12681946/12859_2019_3043_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fad/6720940/b10d6aaf875e/12859_2019_3043_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fad/6720940/e993d56b6064/12859_2019_3043_Fig6_HTML.jpg

相似文献

1
SigsPack, a package for cancer mutational signatures.SigsPack,用于癌症突变特征的软件包。
BMC Bioinformatics. 2019 Sep 2;20(1):450. doi: 10.1186/s12859-019-3043-7.
2
decompTumor2Sig: identification of mutational signatures active in individual tumors.decompTumor2Sig:鉴定个体肿瘤中活跃的突变特征。
BMC Bioinformatics. 2019 Apr 18;20(Suppl 4):152. doi: 10.1186/s12859-019-2688-6.
3
SomaticSignatures: inferring mutational signatures from single-nucleotide variants.体细胞突变特征:从单核苷酸变异推断突变特征。
Bioinformatics. 2015 Nov 15;31(22):3673-5. doi: 10.1093/bioinformatics/btv408. Epub 2015 Jul 10.
4
The Mutational Signature Comprehensive Analysis Toolkit (musicatk) for the Discovery, Prediction, and Exploration of Mutational Signatures.突变特征综合分析工具包(musicatk),用于发现、预测和探索突变特征。
Cancer Res. 2021 Dec 1;81(23):5813-5817. doi: 10.1158/0008-5472.CAN-21-0899. Epub 2021 Oct 8.
5
Analysis of mutational signatures with yet another package for signature analysis.使用另一个签名分析包分析突变特征。
Genes Chromosomes Cancer. 2021 May;60(5):314-331. doi: 10.1002/gcc.22918. Epub 2020 Dec 31.
6
MutSignatures: an R package for extraction and analysis of cancer mutational signatures.MutSignatures:一个用于提取和分析癌症突变特征的 R 包。
Sci Rep. 2020 Oct 26;10(1):18217. doi: 10.1038/s41598-020-75062-0.
7
MutationalPatterns: the one stop shop for the analysis of mutational processes.突变模式:分析突变过程的一站式商店。
BMC Genomics. 2022 Feb 15;23(1):134. doi: 10.1186/s12864-022-08357-3.
8
Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.对 7815 个癌症外显子组的分析揭示了突变过程与体细胞驱动突变之间的关联。
PLoS Genet. 2018 Nov 9;14(11):e1007779. doi: 10.1371/journal.pgen.1007779. eCollection 2018 Nov.
9
Impact of cancer mutational signatures on transcription factor motifs in the human genome.癌症突变特征对人类基因组转录因子基序的影响。
BMC Med Genomics. 2019 May 20;12(1):64. doi: 10.1186/s12920-019-0525-4.
10
Bioinformatic Methods to Identify Mutational Signatures in Cancer.生物信息学方法在癌症突变特征识别中的应用。
Methods Mol Biol. 2021;2185:447-473. doi: 10.1007/978-1-0716-0810-4_28.

引用本文的文献

1
Benchmarking 13 tools for mutational signature attribution, including a new and improved algorithm.对13种用于突变特征归因的工具进行基准测试,包括一种新的改进算法。
Brief Bioinform. 2024 Nov 22;26(1). doi: 10.1093/bib/bbaf042.
2
MUSE-XAE: MUtational Signature Extraction with eXplainable AutoEncoder enhances tumour types classification.MUSE-XAE:基于可解释自动编码器的突变特征提取增强肿瘤类型分类。
Bioinformatics. 2024 May 2;40(5). doi: 10.1093/bioinformatics/btae320.
3
Oxidative stress accelerates intestinal tumorigenesis by enhancing 8-oxoguanine-mediated mutagenesis in MUTYH-deficient mice.

本文引用的文献

1
COSMIC: the Catalogue Of Somatic Mutations In Cancer.COSMIC:癌症体细胞突变目录。
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947. doi: 10.1093/nar/gky1015.
2
The therapeutic significance of mutational signatures from DNA repair deficiency in cancer.DNA 修复缺陷所致突变特征在癌症治疗中的意义。
Nat Commun. 2018 Aug 17;9(1):3292. doi: 10.1038/s41467-018-05228-y.
3
The effects of mutational processes and selection on driver mutations across cancer types.突变过程和选择对不同癌症类型驱动突变的影响。
氧化应激通过增强 MUTYH 缺陷小鼠中 8-氧鸟嘌呤介导的突变加速肠道肿瘤发生。
Genome Res. 2024 Feb 7;34(1):47-56. doi: 10.1101/gr.278326.123.
4
mSigHdp: hierarchical Dirichlet process mixture modeling for mutational signature discovery.mSigHdp:用于突变特征发现的层次狄利克雷过程混合建模
NAR Genom Bioinform. 2023 Jan 23;5(1):lqad005. doi: 10.1093/nargab/lqad005. eCollection 2023 Mar.
5
Unravelling the instability of mutational signatures extraction archetypal analysis.解析突变特征提取原型分析的不稳定性。
Front Genet. 2023 Jan 4;13:1049501. doi: 10.3389/fgene.2022.1049501. eCollection 2022.
6
Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer.可溶性鸟苷酸环化酶信号转导介导进展期小细胞肺癌对依托泊苷的耐药性。
Nat Commun. 2021 Nov 17;12(1):6652. doi: 10.1038/s41467-021-26823-6.
7
XPC deficiency increases risk of hematologic malignancies through mutator phenotype and characteristic mutational signature.XPC 缺陷通过诱变表型和特征性突变特征增加血液系统恶性肿瘤的风险。
Nat Commun. 2020 Nov 17;11(1):5834. doi: 10.1038/s41467-020-19633-9.
8
Characteristics of mutational signatures of unknown etiology.病因不明的突变特征
NAR Cancer. 2020 Sep;2(3):zcaa026. doi: 10.1093/narcan/zcaa026. Epub 2020 Sep 25.
Nat Commun. 2018 May 10;9(1):1857. doi: 10.1038/s41467-018-04208-6.
4
MutationalPatterns: comprehensive genome-wide analysis of mutational processes.突变模式:全面的全基因组突变过程分析。
Genome Med. 2018 Apr 25;10(1):33. doi: 10.1186/s13073-018-0539-0.
5
Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis.突变特征揭示了在肝脏肿瘤发生过程中,风险因素和细胞过程的动态相互作用。
Nat Commun. 2017 Nov 3;8(1):1315. doi: 10.1038/s41467-017-01358-x.
6
Detecting presence of mutational signatures in cancer with confidence.准确检测癌症中突变特征的存在。
Bioinformatics. 2018 Jan 15;34(2):330-337. doi: 10.1093/bioinformatics/btx604.
7
Computational approaches for discovery of mutational signatures in cancer.癌症中突变特征发现的计算方法。
Brief Bioinform. 2019 Jan 18;20(1):77-88. doi: 10.1093/bib/bbx082.
8
Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer.使用经CRISPR修饰的人类干细胞类器官来研究癌症中突变特征的起源。
Science. 2017 Oct 13;358(6360):234-238. doi: 10.1126/science.aao3130. Epub 2017 Sep 14.
9
DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution.DeconstructSigs:剖析单个肿瘤中的突变过程可区分DNA修复缺陷和癌演变模式。
Genome Biol. 2016 Feb 22;17:31. doi: 10.1186/s13059-016-0893-4.
10
A Simple Model-Based Approach to Inferring and Visualizing Cancer Mutation Signatures.一种基于简单模型的癌症突变特征推断与可视化方法。
PLoS Genet. 2015 Dec 2;11(12):e1005657. doi: 10.1371/journal.pgen.1005657. eCollection 2015 Dec.